Biography

Aimaz Afrough, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in multiple myeloma and other plasma cell dyscrasias, developing cellular therapy such as CAR T-cells with or without transplant, and immunotherapy.

Dr. Afrough earned her medical degree at Tabriz University of Medical Sciences in Iran and completed a residency in internal medicine at St. Agnes Hospital in Baltimore. She received advanced training through a hematology and oncology fellowship at Baylor College of Medicine and a stem cell transplantation and cellular therapy fellowship at the University of Texas MD Anderson Cancer Center.

Certified by the American Board of Internal Medicine in medical oncology and hematology, she joined the UT Southwestern faculty in 2021.

Dr. Afrough’s clinical research is focused on improving the therapy and outcome of patients with plasma cell disorders. She is particularly interested in developing novel therapeutic approaches, including adoptive cell therapy to improve the safety and efficacy of therapies in patients with these disorders. She has published numerous academic articles and delivered multiple presentations.

She is a member of several professional associations, including the American Society of Clinical Oncology, the American Society of Hematology, the American Society for Transplantation and Cellular Therapy, and the International Myeloma Society.

In 2019, Dr. Afrough received the Cancer Prevention and Research Institute of Texas (CPRIT) Training Award from the Baylor College of Medicine Comprehensive Cancer Training Program.

Education & Training
  • Medical School - Tabriz University (2002-2008)
  • Residency - St. Agnes Hospital (2014-2017), Internal Medicine
  • Fellowship - Baylor College of Medicine (2017-2020), Hematology Oncology
  • Fellowship - University of Texas MD Anderson Cancer Center (2020-2021), Stem Cell Transplantation & Cellular Therapy
Professional Associations & Affiliations
  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Society for Transplantation and Cellular Therapy
  • International Myeloma Society
  • Society of Hematologic Oncology
Honors & Awards
  • ASCO Reviewer Mentoring Program 2020, Section of JCO Global Oncology
  • Certificate of Added Qualification in Clinical Investigation 2020, Baylor College of Medicine Clinical Scientist Training Program
  • CPRIT Training Award 2019, Baylor College of Medicine Comprehensive Cancer Training Program
  • Travel Fellowship Award 2014, XIVth International Symposium on Amyloidosis
Books & Publications
Research
  • Developing Cellular Therapy such as CAR T Cells With or Without Transplant
  • High-risk Multiple Myeloma
  • Multiple Myeloma and other Plasma Cell Dyscrasia
  • Immunotherapy

Clinical Focus

  • Plasma cell disorders
  • Stem cell transplantation

See More